Payment overview · 2025
General Payments
$198.56
11 reported records · 4 companies
Healthcare provider profile · identity verified
Michael O Crews, DO
Allopathic & Osteopathic Physicians|Family Medicine · BLAND, VA · NPI 1215915137
Verified facts
What the public records show
CMS Open Payments records show Michael O Crews, DO received $198.56 in general payments during 2025 across 11 reported records.
ABBVIE INC. accounted for 69.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Vraylar.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Vraylar by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Farxiga by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 87 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $137.86 | 69.4% | 8 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $21.65 | 10.9% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $21.31 | 10.7% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $17.74 | 8.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $198.56 | 11 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $137.86 | 8 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $21.65 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $21.65 | 1 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $21.31 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $17.74 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| VRAYLAR vraylar |
2025 | Vraylar | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
46 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
46 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
87 | 19 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 402 | 54 |
| Omeprazole | Omeprazole | 398 | 54 |
| Pantoprazole Sodium | Pantoprazole Sodium | 317 | 43 |
| Famotidine | Famotidine | 311 | 40 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 281 | 38 |
| Gabapentin | Gabapentin | 272 | 33 |
| Furosemide | Furosemide | 268 | 46 |
| Oxycodone Hcl | Oxycodone Hcl | 253 | 26 |
| Alprazolam | Alprazolam | 221 | 25 |
| Montelukast Sodium | Montelukast Sodium | 200 | 32 |
| Potassium Chloride | Potassium Chloride | 190 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 169 | 18 |
| Alendronate Sodium | Alendronate Sodium | 168 | 19 |
| Amlodipine Besylate | Amlodipine Besylate | 168 | 30 |
| Lisinopril | Lisinopril | 166 | 26 |
| Trazodone Hcl | Trazodone Hcl | 156 | 26 |
| Metformin Hcl | Metformin Hcl | 150 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 149 | 23 |
| Atorvastatin Calcium | Atorvastatin Calcium | 134 | 21 |
| Benztropine Mesylate | Benztropine Mesylate | 129 | 12 |
| Risperidone | Risperidone | 128 | 13 |
| Metoprolol Succinate | Metoprolol Succinate | 125 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 123 | 17 |
| Divalproex Sodium | Divalproex Sodium | 116 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 112 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 111 | 12 |
| Metoprolol Tartrate | Metoprolol Tartrate | 107 | 20 |
| Lorazepam | Lorazepam | 106 | 16 |
| Fenofibrate | Fenofibrate Nanocrystallized | 105 | 16 |
| Finasteride | Finasteride | 99 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 99 | 15 |
| Levetiracetam | Levetiracetam | 98 | suppressed |
| Simvastatin | Simvastatin | 95 | 13 |
| Eliquis | Apixaban | 87 | 19 |
| Meloxicam | Meloxicam | 87 | 14 |
| Ondansetron Odt | Ondansetron | 85 | 32 |
| Mirtazapine | Mirtazapine | 83 | 12 |
| Losartan Potassium | Losartan Potassium | 82 | 16 |
| Sertraline Hcl | Sertraline Hcl | 82 | 12 |
| Aripiprazole | Aripiprazole | 80 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 80 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 79 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 77 | suppressed |
| Ibuprofen | Ibuprofen | 76 | 43 |
| Clopidogrel | Clopidogrel Bisulfate | 75 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 74 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 74 | suppressed |
| Clonazepam | Clonazepam | 71 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 70 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 70 | 13 |
| Carvedilol | Carvedilol | 66 | suppressed |
| Januvia | Sitagliptin Phosphate | 65 | 12 |
| Topiramate | Topiramate | 65 | suppressed |
| Ezetimibe | Ezetimibe | 64 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 64 | 17 |
| Gemfibrozil | Gemfibrozil | 64 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 62 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 60 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 59 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 59 | 11 |
| Clonidine Hcl | Clonidine Hcl | 59 | suppressed |
| Olanzapine | Olanzapine | 58 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 57 | suppressed |
| Sucralfate | Sucralfate | 56 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 55 | suppressed |
| Celecoxib | Celecoxib | 53 | suppressed |
| Pregabalin | Pregabalin | 53 | suppressed |
| Lactulose | Lactulose | 52 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 52 | suppressed |
| Diazepam | Diazepam | 50 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 49 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 47 | suppressed |
| Linzess | Linaclotide | 46 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 46 | suppressed |
| Synthroid | Levothyroxine Sodium | 46 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | suppressed |
| Haloperidol | Haloperidol | 44 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 42 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 41 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 41 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 40 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 40 | suppressed |
| Nitroglycerin | Nitroglycerin | 40 | 11 |
| Prazosin Hcl | Prazosin Hcl | 40 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 39 | suppressed |
| Spironolactone | Spironolactone | 39 | suppressed |
| Atenolol | Atenolol | 38 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 38 | 11 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 37 | suppressed |
| Lamotrigine | Lamotrigine | 36 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 36 | suppressed |
| Tradjenta | Linagliptin | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 35 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 35 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 35 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 34 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 32 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 32 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 31 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 30 | suppressed |
| Jardiance | Empagliflozin | 30 | suppressed |
| Myrbetriq | Mirabegron | 30 | suppressed |
| Baclofen | Baclofen | 29 | suppressed |
| Carbamazepine | Carbamazepine | 28 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 28 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 28 | suppressed |
| Pentoxifylline | Pentoxifylline | 28 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 18 |
| Cilostazol | Cilostazol | 27 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 27 | suppressed |
| Glipizide | Glipizide | 26 | suppressed |
| Glipizide Er | Glipizide | 26 | suppressed |
| Premarin | Estrogens, Conjugated | 26 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 12 |
| Trimethoprim | Trimethoprim | 24 | suppressed |
| Xifaxan | Rifaximin | 24 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 23 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 23 | suppressed |
| Estradiol | Estradiol | 23 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | suppressed |
| Methocarbamol | Methocarbamol | 22 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 22 | suppressed |
| Allopurinol | Allopurinol | 21 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 21 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 21 | suppressed |
| Ozempic | Semaglutide | 21 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 21 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 20 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 20 | suppressed |
| Metolazone | Metolazone | 20 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 20 | suppressed |
| Prednisone | Prednisone | 20 | suppressed |
| Telmisartan | Telmisartan | 20 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Azithromycin | Azithromycin | 18 | 15 |
| Bupropion Xl | Bupropion Hcl | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 14 |
| Lubiprostone | Lubiprostone | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 16 | suppressed |
| Glimepiride | Glimepiride | 16 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 15 | suppressed |
| Movantik | Naloxegol Oxalate | 15 | suppressed |
| Praluent Pen | Alirocumab | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Clobazam | Clobazam | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Kerendia | Finerenone | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 13 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | suppressed |
| Oxycontin | Oxycodone Hcl | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Clindamycin-Benzoyl Peroxide | Clindamycin Phos/Benzoyl Perox | 12 | suppressed |
| Desipramine Hcl | Desipramine Hcl | 12 | suppressed |
| Elmiron | Pentosan Polysulfate Sodium | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 12 | suppressed |
| Lamotrigine Er | Lamotrigine | 12 | suppressed |
| Levocarnitine | Levocarnitine | 12 | suppressed |
| Memantine Hcl | Memantine Hcl | 12 | suppressed |
| Mesalamine Er | Mesalamine | 12 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 12 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 12 | suppressed |
| Mitigare | Colchicine | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Rufinamide | Rufinamide | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 12 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Belsomra | Suvorexant | 11 | suppressed |
| Cephalexin | Cephalexin | 11 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 11 | suppressed |
| Rexulti | Brexpiprazole | 11 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 11 | suppressed |
| Tadalafil | Tadalafil | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
| Vraylar | Cariprazine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $198.56 · 11 records | ABBVIE INC. | BREZTRI, Cologuard Collection Kit, NURTEC ODT, VRAYLAR, ZAVZPRET | 5 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Vraylar play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error